Phlebotomy to Reduce Iron Overload in Patients Cured of Thalassemia by Bone Marrow Transplantation
نویسندگان
چکیده
In thalassemia after successful bone marrow transplantation tin decreased from 2,587 (2,129 to 4,817) to 417 (210 to 982) (BMT), iron overload remains an important cause of morbidmg/L (PÚ .0001), total transferrin increased from 2.34Ô 0.37 ity. After BMT, patients have normal erythropoiesis capable to 2.7Ô 0.58 g/L (P! .0001), transferrin saturation decreased of producing a hyperplastic response to phlebotomy so that from 90%Ô 14% to 50%Ô 29% (PÚ .0001). Liver iron concenthis procedure can be contemplated as a method of mobiliztration evaluated on liver biopsy specimens decreased from ing iron from overloaded tissues. A phlebotomy program (6 20.8 (15.5 to 28.1) to 4.2 (1.6 to 14.6) mg/g dry weight (P Ú mL/kg blood withdrawal at 14-day intervals) was proposed .0001). Aspartate transaminase decreased from 2.7 Ô 2 to to 48 patients with prolonged follow-up (range, 2 to 7 years) 1.1 Ô 0.6 (P Ú .0001) and alanine transaminase from 5.2 Ô after BMT. Seven patients were not submitted to the pro3.4 to 1.7Ô 1.2 (PÚ .0001) times the upper level of normality. gram (five because of refusal and two because of reversible The Knodell score for liver histological activity decreased side effects). The remaining 41 patients (mean age, 16 Ô 2.9 from 6.9 Ô 3 to 4.9 Ô 2.8 (P Ú .0001). These data indicate years) were treated for a mean period of 35 Ô 18 months. that phlebotomy is safe, efficient, and widely applicable to All were evaluated before and after 3 Ô 0.6 years of followex-thalassemics after BMT. up. Values are expressed as mean Ô standard deviation (SD) q 1997 by The American Society of Hematology. or as median with a range (25 to 75 percentile). Serum ferri-
منابع مشابه
Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients.
In thalassemia after successful bone marrow transplantation (BMT), iron overload remains an important cause of morbidity. After BMT, patients have normal erythropoiesis capable of producing a hyperplastic response to phlebotomy so that this procedure can be contemplated as a method of mobilizing iron from overloaded tissues. A phlebotomy program (6 mL/kg blood withdrawal at 14-day intervals) wa...
متن کاملمروری بر تالاسمی و عوارض ناشی از آن
Thalassemia is a highly progressive hemolytic anemia with different levels of complexity in patients. In thalassemia, reduced level of synthesis of hemoglobin chains results in an imbalanced production of alpha and beta globin chains, and sedimentation of unpaired chains inside red blood cells is the beginning of complications among thalassemia patients. Nowadays compatible blood transfusion is...
متن کاملHepatic iron overload and fibrosis in patients with beta thalassemia major after hematopoietic stem cell transplantation: A pilot study
Currently, hematopoietic stem cell transplantation (HSCT) is the only curative option for patients with beta-thalassemia major, but liver iron overload in these patients will not decrease and hepatic fibrosis may still progress despite successful HSCT. Liver biopsy samples were taken from 14 patients (Out of 25 patients) who underwent HSCT. All patients met three criteria: negative HCV antibody...
متن کاملBone Marrow Transplantation in Thalassemia (Part 2)
During the last two decades conventional therapy has improved the prognosis of thalassemia. However, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. Bone marrow transplantation (BMT) can prevent or delay progression of the aforementioned complications. The importance of clinical research...
متن کاملBone Marrow Transplantation in Thalassemia (Part 1)
During the last two decades conventional therapy has improved the prognosis of thalassemia. However, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. Bone marrow transplantation (BMT) can prevent or delay progression of the aforementioned complications. The importance of clinical research...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 1997